Valcyte Related Clinical Trials
WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (ValcyteŽ) at a Dose of 900mg in Kidney Transplant Recipients [Terminated]
IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients [Active, not recruiting]
Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV) [Active, not recruiting]
Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation [Active, not recruiting]
VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients [Active, not recruiting]
A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients [Completed]
Suppression of Oral HHV8 Shedding With Valganciclovir [Completed]
A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. [Completed]
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection [Active, not recruiting]
Valganciclovir in Congenital CMV Infants [Completed]
Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease [Not yet recruiting]
A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation [Recruiting]
Oral Valganciclovir Versus Valacyclovir [Completed]
Efficacy and Safety of ValcyteŽ as an Add-on Therapy in Patients With Malignant Glioblastoma and CMV Infection [Recruiting]
Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections [Recruiting]
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer [Active, not recruiting]
Study of Prophylactic Vs Preemptive Valganciclovir [Completed]
Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation [Active, not recruiting]
Pharmacokinetics of Mmf and Valganciclovir [Recruiting]
Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients [Completed]
Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT) [Recruiting]
MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus [Recruiting]
Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy [Recruiting]
Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma [Completed]
A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS [Completed]
TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant [Recruiting]
Valganciclovir to Reduce T Cell Activation in HIV Infection [Recruiting]
Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV [Completed]
Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant [Suspended]
CerticanŽ (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients [Recruiting]
Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients [Not yet recruiting]
The Study is Being Done to See If Taking the Drug Valganciclovir Can Prevent CMV Infection. [Recruiting]
Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies [Recruiting]
Study of HQK-1004 and Ganciclovir/Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders [Not yet recruiting]
Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma [Completed]
Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients [Completed]
Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV) [Recruiting]
Antiretroviral Therapy With or Without Bortezomib or Combination Chemotherapy and Rituximab or Sirolimus Only or Observation Only in Treating Patients With Castleman's Disease [Recruiting]
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes [Completed]
Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients [Completed]
Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients [Recruiting]
Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients [Recruiting]
|
